1373rd Deus Ex

Latest website: So when Pfizer invests in these projects, it naturally has more grasp than those outside investors.

But what they have to do now is to make this kind of combination of production and investment model in China, and start doing it!

What Lab Ninth needs to do now is to replicate what Pfizer did in the United States.

If this set is done, it will not only be a matter of making money, but the most important thing is to improve the status of the company in the industry.

Just like Pfizer, you need to know that this company has a huge influence in the beautiful country.

It can even be said that no matter where they go, they are the one with their own halo.

People who are not in the medical circle may not know that the representatives of this company, no matter where they go in the industry, are the objects of others' pursuit of stars.

Why is this happening?

In fact, it is because they have done a good job combining production and investment.

They not only develop various new drugs by themselves, but also make money with a group of younger brothers while making money by themselves.

He is well-known in the industry for his charity, as long as your business is creative and passes their evaluation, then you can get money from him.

And the prices and conditions are very fair.

This is much easier than going to venture capitalists to get money.

In fact, many pharmaceutical companies have a headache when they start, that is, how to obtain sufficient initial start-up capital.

Although in the beautiful country, there are many kinds of angel funds and venture capital.

But unlike those companies engaged in the Internet, those companies can easily get initial funds from venture capitalists.

However, it is difficult for those engaged in pharmaceutical research and development to obtain funds, because the risk of failure in their research and development is too great, and venture capital is not willing to invest money in them.

Moreover, the research and development cycle is long, and it is very likely that money will be continuously invested in it for a long time, so ordinary investors are not willing to invest in this kind of research and development enterprises.

In addition, even if someone is willing to invest,

The requirements will also be very harsh, and they will ask for very high shares at every turn, or assign people to the R&D team to mess around.

Or what's more, they will directly ask to take away the results of research and development.

Therefore, many people engaged in pharmaceutical research and development do not like to deal with investors such as venture capital and angel funds, because in their view, these investors are robbers and liars.

On the other hand, a big company like Pfizer, in their view, is much more kind.

After all, first of all, we are colleagues, and everyone understands the suffering of developing dogs.

The second is that Pfizer is better able to know the value of the projects they develop, so the requirements will not be too much.

Because of this, every year when Pfizer holds a pharmaceutical expo, countless small and medium-sized pharmaceutical companies, and even university research groups, sign up to participate in it across the United States and even around the world.

Because this is a very good platform that Pfizer provides for everyone to showcase themselves.

Here, if your ideas and projects can attract the attention of Pfizer and get their investment, then you are not far from success.

Even if you can't get Pfizer's favor here, you still have the chance to get the attention of other pharmaceutical companies.

Even if you can't get investment from other pharmaceutical companies, at least you have the opportunity to get in touch with some maverick investors.

You must know that in this business, there are always a few investors with very unique vision.

If you can get their attention and investment, then you can also get the initial start-up capital.

This is the main reason why Pfizer has the status it has today.

What the Ninth Laboratory and Xiao Feng have to do now is to learn and apply Pfizer's methods in China.

We must know that the field of original research medicine in China has always been very backward.

In the past few decades, they were mainly catching up. At that time, the main purpose of the major pharmaceutical companies in the country was to make medicine available to the common people in the country.

In the past two decades, the basic drug needs of domestic residents have been met.

However, many pharmaceutical factories in China are backed by a large market and can easily get food, so the pursuit of original research drugs is not so great.

After all, the original drug requires too much investment, the cycle is long, the investment is high, and the effect is slow. No boss is willing to engage in such a project.

Therefore, there are many high-end drug markets in China, which are basically monopolized by large pharmaceutical companies in Europe, America and Japan.

Recently, the state has also noticed this problem, so it is also encouraging domestic pharmaceutical companies to start to take the route of R&D and innovation.

So recently, major domestic pharmaceutical companies have also stepped up research in this area.

In domestic medical universities, there are still many project groups, all of which are keeping up with international trends and looking for the latest and most suitable research and development routes.

Even in China, many small companies have sprung up like bamboo shoots after the rain recently, relying on Internet thinking, they are also engaged in research and development.

In fact, these small and medium-sized enterprises, as well as research groups in universities, are very worthy of investment, and they are indeed in urgent need of funds.

But suffering from the lack of a suitable channel to get funds.

For example, research groups in domestic medical universities mainly rely on school funding for their funding sources.

To be honest, the school's allocation of funds is really very limited for the dozens of project teams that are waiting to be fed.

Everyone can get a little bit every year, and it would be nice to be able to guarantee that they will not starve to death.

As for those small and medium-sized enterprises, the same is true. Obviously, the people in the company are very creative, but in the process of research and development, they need a lot of capital investment.

And even if the data in the laboratory is successful, when the next step is to conduct in vivo clinical trials, these small companies will be blinded.

Even if they can afford the initial cost, the cost of the later in vivo clinical trials will be too high.

Domestic clinical trials will take five years, and the collection of data will basically start with tens of thousands.

This kind of consumption, apart from those large pharmaceutical factories in China, or only the national research institutes can afford it.

For small and medium-sized pharmaceutical companies, their work is basically over at this point.

After all, they cannot afford to conduct clinical trials overseas, although clinical trials in India and Africa are very cheap.

But they don't have such resources, and they are not familiar with the place, so they can't afford to invest at all.

So generally at this point, the first choice of these pharmaceutical companies is to sell their research results.

And their first choice is to sell to large foreign manufacturers, because it is true that these large foreign manufacturers will pay a good price.

And these large foreign pharmaceutical companies, although they spent a little money to obtain these results, compared with what they got, the little money they paid was just a drop in the bucket.

Because these small and medium-sized pharmaceutical R&D companies in Huaguo have completed the most difficult early stage of a project, from creativity to laboratory experiments in the later stage, and the collection of laboratory data has been completed.

And in the end, all they have to do is to complete the clinical trial, and this step is nothing to them at all.

Once the last step is completed, they can apply for a new drug to be marketed. At that time, this drug will bring them tens of billions of dollars in the global market.

This is really not an exaggeration at all!

And looking back, they will support their local media, saying that the people of H country have no sense of innovation...

Anyway, such a fucking thing is not a secret that can't be told in the medical circle.

However, Xiao Feng didn't know about this when he didn't enter the industry before, but after learning about it, he would always feel pity and distress for those domestic companies.

No way, who made it impossible for us to reach out and give them a hand at that time!

But now it's all right, their Ninth Laboratory is finally strong.

Moreover, there are so many rich capitals and bigwigs in the country. In fact, many of these people also want to invest in the pharmaceutical industry.

After all, the aging of the country is already very serious, and everyone knows that the future of the big health industry will definitely have a lot to do.

However, the barriers to entry in the medical field are not low. Not only do you need money, the most important thing is that you need to have enough knowledge of the medical field.

Knowing that the business can be done, and that business is completely a liar, so you can avoid being cheated.

Because of this, those bigwigs and capitals are very cautious about investing in small and medium-sized pharmaceutical companies.

What the Ninth Laboratory needs to do is to integrate the resources of both sides, and then make a connection between them.

What Xiao Feng meant was to set up a large exhibition hall in the new sports city section that was about to start construction.

Usually, it can undertake various exhibitions, and at a fixed time every year, the Ninth Laboratory can also come forward to organize large-scale pharmaceutical expos and medical equipment expos across the country.

With the status of the Ninth Laboratory in the domestic pharmaceutical industry today, they ascend to the top and say that those large domestic pharmaceutical companies and hospitals really have to give face.

And presumably they will also like it, there is such a platform that allows them to have the opportunity to receive pharmaceutical companies and hospitals across the country.

At the same time, they will also give an opportunity to pharmaceutical companies across the country engaged in original research drugs, or pharmaceutical companies engaged in medical device development.

Let them showcase their ideas on this platform, and if their ideas are recognized by the Ninth Lab, they can get investment from Quanye Fund.

In addition, their platform can also help other capital and bigwigs who are interested in investing in pharmaceutical companies find suitable targets here.

Anyway, Xiao Feng's original intention was to make money for everyone.

As long as this combination of production and investment is done well, domestic pharmaceutical research and development will be on a bright road in the future.

And their Ninth Laboratory, and Quanye Fund, can rely on this move to establish their status in the domestic medical world in one fell swoop.

Now the field of medicine in China can be said to be an era in which all heroes rise together.

The established state-owned enterprises are still old and getting stronger, and many private pharmaceutical companies of the new generation are also emerging.

And when this platform is completed, that is when the Ninth Lab will stand out!